Furthermore, previous studies have proposed GP73 as a novel biomarker for HBV‐related hepatocellular carcinoma (HCC) and revealed that this is markedly increased in HCC patients [9, 10]. Here, GOLM1 is linked to hepatocellular carcinoma.